|

HP Pyruvate MRI in Cancers

RECRUITINGPhase 1/2Sponsored by University of Maryland, Baltimore
Actively Recruiting
PhasePhase 1/2
SponsorUniversity of Maryland, Baltimore
Started2024-06-24
Est. completion2026-12-01
Eligibility
Age18 Years – 88 Years
Healthy vol.Accepted
Locations1 site

Summary

Many human diseases are characterized by their ability to alter existing metabolic pathways and interrupt cellular processes. Cancer exploits the Warburg effect and utilizes greater glucose than normal cells and within this process uses anaerobic respiration, leading to increased conversion of pyruvate to lactate. This can be exploited by hyperpolarized imaging. Hyperpolarized 13C MRI imaging is an approach that utilizes a stable isotope of Carbon (13C) linked to pyruvate. MRI spectroscopy is used in conjunction with hyperpolarized 13C pyruvate in order to temporally detect pyruvate and its conversion to lactate in-vivo, in order to visualize downstream metabolic (glycolytic) activity secondary to the Warburg effect, which should be useful in detecting and characterizing tumors of various types. Hyperpolarized 13C pyruvate MR imaging has not been tested in most cancers. In this preliminary survey, we will test the hypothesis that hyperpolarized 13C pyruvate MR imaging can be used to image various cancers.

Eligibility

Age: 18 Years – 88 YearsHealthy volunteers accepted
Inclusion Criteria:

Clinical tumor diagnosis

Patients with pre-existing MR imaging appointments

Must be able to undergo MR

Exclusion Criteria:

No tumor diagnosis

Conditions4

CancerImageTumorsWarburg Effect

Locations1 site

University of Maryland Medical Center
Baltimore, Maryland, 21201
Rosy Njonkou, MA410-706-0943rnjonkou@som.umaryland.edu

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.